Rare copy number variation in cerebral palsy

European Journal of Human Genetics

Volumn 22, Issue 1, 2014, Pages 40-45

  McMichael, Gai ^a   Girirajan, Santhosh ^b   Moreno De Luca, Andres ^c   Gecz, Jozef ^d,e   Shard, Chloe ^e   Nguyen, Lam Son ^e   Nicholl, Jillian ^d   Gibson, Catherine ^a   Haan, Eric ^e   Eichler, Evan ^b   Martin, Christa Lese ^f   MacLennan, Alastair ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c GENOMIC MEDICINE INSTITUTE   (United States)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cerebral palsy; copy number; microarray

Indexed keywords

ADULT; ARTICLE; CAUCASIAN; CEREBRAL PALSY; COHORT ANALYSIS; CONTROLLED STUDY; COPY NUMBER VARIATION; EXON; FATHER; FEMALE; GENE; GENE DELETION; GENE DUPLICATION; GENE MUTATION; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOTHER; PRIORITY JOURNAL; GENE FREQUENCY; GENETICS; INFANT; NEWBORN; PATHOLOGY;

CATENIN; COPS3 PROTEIN, HUMAN; DAAM1 PROTEIN, HUMAN; DELTA CATENIN; MCPH1 PROTEIN, HUMAN; NERVE PROTEIN; ONCOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; CATENINS; CEREBRAL PALSY; DNA COPY NUMBER VARIATIONS; EXONS; FEMALE; GENE FREQUENCY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROARRAY ANALYSIS; NERVE TISSUE PROTEINS; PROTO-ONCOGENE PROTEINS; SEQUENCE DELETION;

EID: 84890791333     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2013.93     Document Type: Article

References (48)

1. Nelson KB, Dambrosia JM, Grether JK, Phillips TM: Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998; 44: 665-675.
2. MacLennan A: A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ 1999; 319: 1054-1059.
3. Rosenbaum P, Paneth N, Leviton A et al: A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl 2007; 109: 8-14.
4. Strijbis EM, Oudman I, van Essen P, MacLennan AH: Cerebral palsy and the application of the international criteria for acute intrapartum hypoxia. Obstet Gynecol 2006; 107: 1357-1365.
5. O'Callaghan ME, MacLennan AH, Gibson CS et al: Epidemiolgic associations with cerebral palsy. Obstet Gynaecol 2011; 118: 576-582.
6. Moreno-De-Luca A, Ledbetter DH, Martin CL: Genomic insights into the causes and classification of the cerebral palsies. Lancet Neurol 2012; 11: 283-292.
7. Petterson B, Stanley F, Henderson D: Cerebral palsy in multiple births in Western Australia: genetic aspects. Am J Med Genet 1990; 37: 346-351.
8. Paneth N: Birth and the origins of cerebral palsy. N Engl J Med 1986; 315: 124-126.
9. Wild NJ, Rosenbloom L: Familial cerebral palsy associated with normal intelligence. Postgrad Med J 1986; 62: 827-830.
10. O'Callaghan ME, MacLennan AH, Haan EA, Dekker G: The genomic basis of cerebral palsy: a HuGE systematic literature review. Hum Genet 2009; 126: 149-172.
11. McHale DP, Mitchell S, Bundey S et al: A gene for autosomal recessive symmetrical spastic cerebral palsy maps to chromosome 2q24-25. Am J Hum Genet 1999; 64: 526-532.
12. Lynex CN, Carr IM, Leek JP et al: Homozygosity for a missense mutation in the 67kDa isoform of glutamate decarboxylase in a family with autosomal recessive spastic cerebral palsy: parallels with Stiff-Person Syndrome and other movement disorders. BMC Neurol 2004; 4: 20.
13. McHale DP, Jackson AP, Campbell et al: A gene for ataxic cerebral palsy maps to chromosome 9p12-q12. Eur J Hum Genet 2000; 8: 267-272.
14. Verkerk AJ, Schot R, Dumee B et al: Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsy. Am J Hum Genet 2009; 85: 40-52.
15. Abou Jamra R, Philippe O, Raas-Rothschild A et al: Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature. Am J Hum Genet 2011; 88: 788-795.
16. Moreno-De-Luca A, Helmers SL, Mao H et al: Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability. J Med Genet 2011; 48: 141-144.
17. Bauer P, Leshinsky-Silver E, Blumkin L et al: Mutation in the AP4B1 gene cause hereditary spastic paraplegia type 47 (SPG47). Neurogenetics 2012; 13: 73-76.
18. Badawi N, Watson L, Petterson B et al: What constitutes cerebral palsy? Dev Med Child Neurol 1998; 40: 520-527.
19. Pinto D, Pagnamenta AT, Klei L et al: Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010; 466: 368-372.
20. Girirajan S, Rosenfeld JA, Cooper GM et al: A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet 2010; 42: 203-209.
21. Cooper G, Coe B, Girirajan S et al: A copy number variation morbidity map of develomental delay. Nat Genet 2011; 43: 838-846.
22. de Kovel CG, Trucks H, Helbig I et al: Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 2010; 133: 23-32.
23. O'Roak BJ, Deriziotis P, Lee C et al: Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 2011; 43: 585-589.
24. Gardosi J: Customised assessment of fetal growth potential: implications for perinatal care. Arch Dis Child Fetal Neonatal Ed 2012; 97: F314-F317.
25. Girirajan S, Brkanac Z, Coe BP et al: Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet 2011; 7: e1002334.
26. Selzer RR, Richmond TA, Pofahl NJ et al: Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. Genes Chromosomes Cancer 2005; 44: 305-319.
27. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B: Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997; 39: 214-223.
28. Carrozzo R, Bellini C, Lucioli S et al: Peroxisomal acyl-CoA-oxidase deficiency: two new cases. Am J Med Genet A 2008; 146A: 1676-1681.
29. Seeger M, Thierse HJ, Lange H, Shaw L, Hansen H, Lemke H: Antigen-independent suppression of the IgE immune response to bee venom phospholipase A2 by maternally derived monoclonal IgG antibodies. Eur J Immunol 1998; 28: 2124-2130.
30. Henke W, Ferrell K, Bech-Otschir D et al: Comparison of human COP9 signalsome and 26S proteasome lid'. Mol Biol Rep 1999; 26: 29-34.
31. Girirajan S, Vlangos CN, Szomju BB et al: Genotype-phenotype correlation in Smith-Magenis syndrome: evidence that multiple genes in 17p11.2 contribute to the clinical spectrum. Genet Med 2006; 8: 417-427.
32. Potocki L, Chen KS, Park SS et al: Molecular mechanism for duplication 17p11.2-the homologous recombination reciprocal of the Smith-Magenis microdeletion. Nat Genet 2000; 24: 84-87.
33. Molina J, Carmona-Mora P, Chrast J et al: Abnormal social behaviors and altered gene expression rates in a mouse model for Potocki-Lupski syndrome. Hum Mol Genet 2008; 17: 2486-2495.
34. Chai JH, Locke DP, Greally JM et al: Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons. Am J Hum Genet 2003; 73: 898-925.
35. Mefford HC, Cooper GM, Zerr T et al: A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease. Genome Res 2009; 19: 1579-1585.
36. Medina M, Marinescu RC, Overhauser J, Kosik KS: Hemizygosity of delta-catenin (CTNND2) is associated with severe mental retardation in cri-du-chat syndrome. Genomics 2000; 63: 157-164.
37. Vrijenhoek T, Buizer-Voskamp JE, van der Stelt I et al: Recurrent CNVs disrupt three candidate genes in schizophrenia patients. Am J Hum Genet 2008; 83: 504-510.
38. Gai X, Xie HM, Perin JC et al: Rare structural variation of synapse and neurotransmission genes in autism. Mol Psychiatry 2012; 17: 402-411.
39. Harvard C, Malenfant P, Koochek M et al: A variant Cri du Chat phenotype and autism spectrum disorder in a subject with de novo cryptic microdeletions involving 5p15.2 and 3p24.3-25 detected using whole genomic array CGH. Clin Genet 2005; 67: 341-351.
40. Lupski JR, Stankiewicz P: Genomic disorders: molecular mechanisms for rearrangements and conveyed phenotypes. PLoS Genet 2005; 1: e49.
41. Evans PD, Anderson JR, Vallender EJ, Choi SS, Lahn BT: Reconstructing the evolutionary history of microcephalin, a gene controlling human brain size. Hum Mol Genet 2004; 13: 1139-1145.
42. Trimborn M, Bell SM, Felix C et al: Mutations in microcephalin cause aberrant regulation of chromosome condensation. Am J Hum Genet 2004; 75: 261-266.
43. Garshasbi M, Motazacker MM, Kahrizi K et al: SNP array-based homozygosity mapping reveals MCPH1 deletion in family with autosomal recessive mental retardation and mild microcephaly. Hum Genet 2006; 118: 708-715.
44. Ozgen HM, van Daalen E, Bolton PF et al: Copy number changes of the microcephalin 1 gene (MCPH1) in patients with autism spectrum disorders. Clin Genet 2009; 76: 348-356.
45. Aza-Carmona M, Barreda-Bonis AC, Guerrero-Fernandez J, Gonzalez-Casado I, Gracia R, Heath KE: Familial glucocorticoid deficiency due to compound heterozygosity of two novel MC2R mutations. J Pediatr Endocrinol Metab 2011; 24: 395-397.
46. Veltman JA, Brunner HG: Understanding variable expressivity in microdeletion syndromes. Nat Genet 2010; 42: 192-193.
47. Raj A, Rifkin SA, Andersen E, van Oudenaarden A: Variability in gene expression underlies incomplete penetrance. Nature 2010; 463: 913-918.
48. Feuk L, Carson AR, Scherer SW: Structural variation in the human genome. Nat Rev Genet 2006; 7: 85-97.